114 related articles for article (PubMed ID: 6861082)
1. Chemohormonal therapy of metastatic prostate cancer. A pilot study.
Citrin DL; Hogan TF; Davis TE
Cancer; 1983 Aug; 52(3):410-4. PubMed ID: 6861082
[TBL] [Abstract][Full Text] [Related]
2. Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implications.
Citrin DL; Elson P; Kies MS; Lind R
Am J Med; 1984 May; 76(5):787-93. PubMed ID: 6539069
[TBL] [Abstract][Full Text] [Related]
3. Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882): an Eastern Cooperative Oncology Group study.
Leaf AN; Propert K; Corcoran C; Catalano PJ; Trump DL; Harris JE; Davis TE
Med Oncol; 2003; 20(2):137-46. PubMed ID: 12835516
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
Citrin DL; Kies MS; Wallemark CB; Khandekar J; Kaplan E; Camacho F; Lind R
Cancer; 1985 Aug; 56(3):457-60. PubMed ID: 4005808
[TBL] [Abstract][Full Text] [Related]
5. A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate.
Seifter EJ; Bunn PA; Cohen MH; Makuch RW; Dunnick NR; Javadpour N; Bensimon H; Eddy JL; Minna JD; Ihde DC
J Clin Oncol; 1986 Sep; 4(9):1365-73. PubMed ID: 2943877
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia during diethylstilbestrol diphosphate (stilphostrol) infusion for carcinoma of the prostate.
Nachtsheim DA; McPherson RA; Pollen JJ; Schmidt JD
Prostate; 1980; 1(1):105-9. PubMed ID: 7279796
[TBL] [Abstract][Full Text] [Related]
7. [Treatment results of combined hormone and chemotherapy in patients with advanced prostate cancer].
Uekado Y
Hinyokika Kiyo; 1991 Aug; 37(8):825-31. PubMed ID: 1957724
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Megace, Stilphostrol, Megace plus DES, or streptozotocin in metastatic prostatic cancer in patients with hormonal failure and prior radiotherapy.
McLeod DG; Murphy GP; Priore R
Urology; 1988 Nov; 32(5):431-6. PubMed ID: 2973171
[TBL] [Abstract][Full Text] [Related]
9. High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens.
Band PR; Banerjee TK; Patwardhan VC; Eid TC
Can Med Assoc J; 1973 Oct; 109(8):697-9. PubMed ID: 4746128
[TBL] [Abstract][Full Text] [Related]
10. Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.
Montgomery RB; Nelson PS; Lin D; Ryan CW; Garzotto M; Beer TM
Cancer; 2007 Sep; 110(5):996-1002. PubMed ID: 17639587
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of the usefulness of endocrine therapy combined with chemotherapy as an initial treatment of prostatic cancer].
Matsuoka K; Yoshitake N; Noguti M; Tanaka H; Noda S; Eto K
Nihon Hinyokika Gakkai Zasshi; 1988 Sep; 79(9):1559-66. PubMed ID: 3244222
[No Abstract] [Full Text] [Related]
12. [A case of advanced prostatic cancer presenting as inguinal mass].
Ikeda K; Niwa N; Oka F; Ito H; Abe H; Nakagami Y
Hinyokika Kiyo; 1991 Jul; 37(7):765-7. PubMed ID: 1927782
[TBL] [Abstract][Full Text] [Related]
13. Chemo-endocrine therapy in patients with stage D2 prostate cancer.
Kubota Y; Nakada T; Imai K; Yamanaka H; Sakai H; Saito Y; Tomaru Y; Kitamura K; Sugano O; Sasagawa I
Prostate; 1995 Jan; 26(1):50-4. PubMed ID: 7845867
[TBL] [Abstract][Full Text] [Related]
14. Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.
Susan LP; Roth RB; Adkins WC
Urology; 1976 Jun; 7(6):598-601. PubMed ID: 936380
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
[TBL] [Abstract][Full Text] [Related]
16. [Combined hormone and chemotherapy for the patients with advanced prostate cancer].
Uekado Y; Hirano A; Inagaki T; Hiroi A; Watanabe T
Gan To Kagaku Ryoho; 1995 Jul; 22(8):1041-5. PubMed ID: 7611755
[TBL] [Abstract][Full Text] [Related]
17. [Estrogen therapy--high-dose intravenous diethylstilbestrol diphosphate therapy for advanced or hormone refractory prostate cancer].
Nakagawa M
Nihon Rinsho; 2002 Dec; 60 Suppl 11():199-204. PubMed ID: 12599571
[No Abstract] [Full Text] [Related]
18. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
Wakisaka M; Takagishi H
Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
[TBL] [Abstract][Full Text] [Related]
19. Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II study.
Izbicki RM; Amer MH; Al-Sarraf M
Cancer Treat Rep; 1979 Jun; 63(6):999-1001. PubMed ID: 380805
[TBL] [Abstract][Full Text] [Related]
20. Oral stilboestrol diphosphate ("Honvan") in the treatment of prostatic carcinoma: a clinical trial.
Lambley DG; Ware JW
Br J Urol; 1967 Apr; 39(2):147-52. PubMed ID: 5337817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
